Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Current Leases: 2023-2024

Historic Current Leases for Fennec Pharmaceuticals (FENC) over the last 1 years, with Dec 2024 value amounting to $2,000.

  • Fennec Pharmaceuticals' Current Leases fell 90.48% to $2,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $2,000, marking a year-over-year decrease of 90.48%. This contributed to the annual value of $2,000 for FY2024, which is 90.48% down from last year.
  • Fennec Pharmaceuticals' Current Leases amounted to $2,000 in Q4 2024, which was down 71.43% from $7,000 recorded in Q3 2024.
  • Fennec Pharmaceuticals' 5-year Current Leases high stood at $21,000 for Q3 2023, and its period low was $2,000 during Q4 2024.
  • In the last 2 years, Fennec Pharmaceuticals' Current Leases had a median value of $14,500 in 2024 and averaged $13,333.
  • Data for Fennec Pharmaceuticals' Current Leases shows a maximum YoY crashed of 90.48% (in 2024) over the last 5 years.
  • Quarterly analysis of 2 years shows Fennec Pharmaceuticals' Current Leases stood at $21,000 in 2023, then crashed by 90.48% to $2,000 in 2024.
  • Its last three reported values are $2,000 in Q4 2024, $7,000 for Q3 2024, and $12,000 during Q2 2024.